Development of a prognostic model for postoperative survival in appendiceal pseudomyxoma peritonei based on clinical indicators. [PDF]
Jiao J +6 more
europepmc +1 more source
CYP2C19 Polymorphism and Platelet Aggregation-Associated Risks in Atrial Fibrillation Patients Undergoing PCI. [PDF]
Gjermeni D +12 more
europepmc +1 more source
Complex CTO Revascularization in Patients with Ischemic Heart Failure and Reduced Ejection Fraction: An Illustrative Case Series. [PDF]
Blaj-Tunduc IP +4 more
europepmc +1 more source
Shao-Bing Yang,1 Hong-Wei Zhao2 1Department of Cardiology, The General Hospital of Ningxia Medical University, Yinchuan, People’s Republic of China; 2Department of Cardiology, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, People’s ...
Yang SB, Zhao HW
doaj
Recent advances in percutaneous coronary intervention for modernizing coronary physiology-guided and device-based strategies for coronary revascularization. [PDF]
Tang D, Mu W.
europepmc +1 more source
Development and validation of a screening scale to predict postdischarge depression in patients with acute coronary syndrome after percutaneous coronary intervention: a prospective longitudinal study. [PDF]
Doi M +7 more
europepmc +1 more source
From angiography-derived physiology guided PCI to INOCA treatment and to coronary sinus reducer: navigating multiple pathophysiological targets in a single patient: a case report. [PDF]
Buri J +4 more
europepmc +1 more source
Early-Onset Myocardial Infarction in a 13-Year-Old With Homozygous Familial Hypercholesterolemia Managed by PCI. [PDF]
Siddiqui FI +7 more
europepmc +1 more source
Predictive value of the uric acid-to-albumin ratio for contrast-induced nephropathy after percutaneous coronary intervention and construction of a clinical prediction model in patients with coronary artery disease. [PDF]
Zhu Y +5 more
europepmc +1 more source
Is Aspirin Still Indispensable After PCI-Rethinking Dual Antiplatelet Therapy in Contemporary Practice. [PDF]
Yadav K +6 more
europepmc +1 more source

